Engineered Protein Against Staphylococcus aureus Toxin
Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics , Microbiology on May 23, 2007
Researchers have engineered a protein which may be counter enterotoxin B, a toxin produced by Staphylococcus aureus, which can cause potentially fatal food poisoning. The purified form of the toxin in considered as a potential bioterrorism agent.
"Our approach was to take these receptors that bind to the toxins and to try to make them higher affinity and therefore act as effective neutralizing agents when delivered in soluble form," Kranz said. "It's the binding of the toxin to T-cells that is critical. If you can prevent the toxin from binding to the T-cell receptor then you can prevent it from initiating that cascade."
The engineered protein prevented the onset of symptoms in rabbits exposed to SEB and reversed the course of the illness in those treated two hours after exposure.
According to the researchers, in comparison to antibodies, this protein is about 1/10th in size and may therefore penetrate deeper into tissues without triggering an immune response. The protein can also be mass produced rapidly and inexpensively using E.coli.
The study has been published in the recent issue of Nature Medicine. See more from the University of Illinois news report.

The engineered protein prevented the onset of symptoms in rabbits exposed to SEB and reversed the course of the illness in those treated two hours after exposure.
Tags: staphylococcus food+poisoning bioterrorism enterotoxin biotech engineered+protein staphylococcus+aur
Vote for Engineered Protein Against Staphylococcus aureus Toxin:
|
Rating: 6.00 out of 2 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
